The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.
Open accessAbstract
The folate antagonist methotrexate (MTX) is extensively used in graft-versus-host disease, rheumatoid arthritis, and other chronic inflammatory disorders. In addition to its antiinflammatory activity associated with increased release of adenosine, MTX exerts antiproliferative properties by inhibition of dihydrofolate reductase and other folate-dependent enzymes. However, the mechanisms of immunosuppressive properties associated with low-dose MTX treatments are still elusive. We report here that MTX (0.1-10 microM) induces apoptosis of in vitro activated T cells from human peripheral blood. PBL exposed to MTX for 8 h, then activated in drug-free medium, underwent apoptosis, which was completely abrogated by addition of folinic acid or thymidine. Apoptosis of activated T cells did not require interaction between CD95 (Fas, APO-1) and its ligand, and adenosine release accounted for only a small part of this MTX activity. Apoptosis required progression of activated T cells to the S phase of the cell cycle, as it was prevented by drugs or antibodies that interfere with IL-2 synthesis or signaling pathways. MTX achieved clonal deletion of activated T cells in mixed lymphocyte reactions. Finally, in vitro activation of PBL taken from rheumatoid arthritis patients after MTX injection resulted in apoptosis. Altogether, the data demonstrate that MTX can selectively delete activated peripheral blood T cells by a CD95-independent pathway. This property could be used as a new pharmacological end point to optimize dosage and timing of MTX administration. It may account for the immunosuppressive effects of low-dose MTX treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
Koopman, G., Reutelingsperger, C., Kuijten, G., Keehnen, R., Pals, S., & van Oers, M. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,681
Storb, R., Deeg, H. J., Whitehead, J., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C. D., Clift, R., Doney, K., Farewell, V., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411
Apoptosis in cancer therapy: Crossing the threshold
Fisher, D. E. (1994) · Cell · doi:10.1016/0092-8674(94)90518-5 · Cited by 1,315
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., & de Villartay, J. P. (1995) · Science · doi:10.1126/science.7539157 · Cited by 1,297
Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., & Kroemer, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1661 · Cited by 1,166
Gorczyca, W., GONG, J., & Darżynkiewicz, Z. (1993) · PubMed · Cited by 982
Friesen, C., Herr, I., Krammer, P. H., & Debatin, K.-M. (1996) · Nature Medicine · doi:10.1038/nm0596-574 · Cited by 974
Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
Weinblatt, M. E., Coblyn, J. S., Fox, D. A., Fraser, P. A., Holdsworth, D. E., Glass, D. N., & Trentham, D. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503283121303 · Cited by 872
Müller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119174 · Cited by 748
Cronstein, B. N., Naime, D., & Ostad, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116884 · Cited by 679
Williams, H. J., Willkens, R. F., Samuelson, C. O., Alarcón, G. S., Guttadauria, M., Yarboro, C., Polisson, R. P., Weiner, S. R., Luggen, M. E., Billingsley, L. M., et al. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280702 · Cited by 462
Polyglutamation of methotrexate. Is methotrexate a prodrug?
Chabner, B. A., Allegra, C. J., Curt, G. A., Clendeninn, N. J., Baram, J., Koizumi, S., Drake, J. C., & Jolivet, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112088 · Cited by 460
Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.
Cronstein, B. N., Levin, R. I., Belanoff, J., Weissmann, G., & Hirschhorn, R. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112638 · Cited by 412
Nash, R., Pepe, M., Storb, R., Longton, G., Pettinger, M., Anasetti, C., Appelbaum, F., Bowden, R., Deeg, H., & Doney, K. (1992) · Blood · doi:10.1182/blood.v80.7.1838.1838 · Cited by 377
Cronstein, B. N., Rosenstein, E. D., Kramer, S. B., Weissmann, G., & Hirschhorn, R. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.2.1366 · Cited by 345
Cronstein, B. N., Eberle, M. A., Gruber, H. E., & Levin, R. I. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2441 · Cited by 332
Allegra, C. J., Drake, J. C., Jolivet, J., & Chabner, B. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4881 · Cited by 310
Almasan, A., Yin, Y., Kelly, R. E., Lee, E. Y., Bradley, A., Li, W., Bertino, J. R., & Wahl, G. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5436 · Cited by 296
Morabito, L., Montesinos, M. C., Schreibman, D. M., Balter, L., Thompson, L. F., Resta, R., Carlin, G., Huie, M. A., & Cronstein, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1554 · Cited by 259
Anti‐immunoglobulins induce death by apoptosis in WEHI‐231 B lymphoma cells
Benhamou, L. E., Cazenave, P., & Sarthou, P. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200630 · Cited by 228
Advances in Chemotherapy of Cancer in Man
(1956) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60721-6 · Cited by 193
Jolivet, J., Schilsky, R. L., Bailey, B. D., Drake, J. C., & Chabner, B. A. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110624 · Cited by 182
Nash, R., Pineiro, L., Storb, R. F., Deeg, H. J., Fitzsimmons, W., Furlong, T., Hansen, J., Gooley, T., Maher, R., Martin, P. J., et al. (1996) · Blood · doi:10.1182/blood.v88.9.3634.bloodjournal8893634 · Cited by 149
Maria, R. D., Boirivant, M., Cifone, M. G., Roncaioli, P., Hahne, M., Tschopp, J., Pallone, F., Santoni, A., & Testi, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118418 · Cited by 128
Fournel, S., Genestier, L., Robinet, É., Flacher, M., & Révillard, J. P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4309 · Cited by 77
Self-citationApoptosis without decrease of cell DNA content
Fournel, S., Genestier, L., Rouault, J.-P., Lizard, G., Flacher, M., Assossou, O. M., & Revillard, J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00532-e · Cited by 53
Self-citationFas-Independent Apoptosis of Activated T Cells Induced by Antibodies to the HLA Class I α1 Domain
Genestier, L., Paillot, R., Bonnefoy, N., Meffre, G., Flacher, M., Fèvre, D., Liu, Y.-J., Bouteiller, P. P. L., Waldmann, H., Engelhard, V. H., et al. (1997) · Blood · doi:10.1182/blood.v90.9.3629 · Cited by 42
Self-citation
Cited by
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
T cell apoptosis by tryptophan catabolism
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022
Van den Brande, J. M. H., Braat, H., van den Brink, G. R., Versteeg, H. H., Bauer, C. A., Hoedemaeker, I., van Montfrans, C., Hommes, D. W., Peppelenbosch, M. P., & van Deventer, S. J. H. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00382-2 · Cited by 723
Development of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673
Metadata
- Authors
- Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., & Revillard, J. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-07-15
- Volume
- 102
- Issue
- 2
- Pages
- 322-328
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2072829987
- Cited by
- 459
- References
- 28
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.